CN103784356B - 芒果活性部位在制备抗氧化化妆品中的应用 - Google Patents
芒果活性部位在制备抗氧化化妆品中的应用 Download PDFInfo
- Publication number
- CN103784356B CN103784356B CN201210422046.3A CN201210422046A CN103784356B CN 103784356 B CN103784356 B CN 103784356B CN 201210422046 A CN201210422046 A CN 201210422046A CN 103784356 B CN103784356 B CN 103784356B
- Authority
- CN
- China
- Prior art keywords
- mangifera indicae
- fructus mangifera
- active site
- application
- indicae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001093152 Mangifera Species 0.000 title claims abstract description 56
- 239000002537 cosmetic Substances 0.000 title claims abstract description 26
- 230000003064 anti-oxidating effect Effects 0.000 title claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 50
- 239000000843 powder Substances 0.000 claims abstract description 14
- 239000000706 filtrate Substances 0.000 claims abstract description 12
- 239000011347 resin Substances 0.000 claims abstract description 9
- 229920005989 resin Polymers 0.000 claims abstract description 9
- 239000003463 adsorbent Substances 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 238000010521 absorption reaction Methods 0.000 claims abstract description 5
- 230000001476 alcoholic effect Effects 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 7
- 239000000287 crude extract Substances 0.000 abstract description 10
- 238000010828 elution Methods 0.000 abstract description 10
- 230000006837 decompression Effects 0.000 abstract description 8
- 238000011084 recovery Methods 0.000 abstract description 8
- 239000002904 solvent Substances 0.000 abstract description 8
- 231100000957 no side effect Toxicity 0.000 abstract description 6
- 238000002481 ethanol extraction Methods 0.000 abstract description 2
- 235000017807 phytochemicals Nutrition 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 229930000223 plant secondary metabolite Natural products 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 25
- -1 catechin Chemical class 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- 230000002000 scavenging effect Effects 0.000 description 16
- 238000012360 testing method Methods 0.000 description 11
- 230000002087 whitening effect Effects 0.000 description 11
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 239000007854 depigmenting agent Substances 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 230000007760 free radical scavenging Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 102000003425 Tyrosinase Human genes 0.000 description 2
- 108060008724 Tyrosinase Proteins 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000208223 Anacardiaceae Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000012639 Balance disease Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000127225 Enceliopsis nudicaulis Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 241000770397 Phyllosticta musarum Species 0.000 description 1
- 241000233614 Phytophthora Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000002044 Rhizophora apiculata Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040829 Skin discolouration Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003026 anti-oxygenic effect Effects 0.000 description 1
- 230000003035 anti-peroxidant effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000009633 chimonin Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 231100000880 dysequilibrium Toxicity 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000021022 fresh fruits Nutrition 0.000 description 1
- LEXBBZCFWJNTGC-UHFFFAOYSA-N gallicin Natural products C1CC(=C)C(O)CCC(C)=CC2OC(=O)C(C)C21 LEXBBZCFWJNTGC-UHFFFAOYSA-N 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 239000003845 household chemical Substances 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002730 mercury Chemical class 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及植物提取物在具有抗氧化作用的化妆品领域中的应用,公开了一种芒果活性部位在具有抗氧化作用化妆品中的应用。这种芒果活性部位的制备方法为取芒果干燥粉末,以乙醇提取,滤液合并,减压回收溶剂,得到芒果粗提物;芒果粗提物经大孔吸附树脂吸附,以乙醇洗脱,收集流份,蒸干,得到芒果活性部位。这种芒果活性部位,是一种天然的植物抗氧化剂,对人体无副作用,在抗氧化领域有应用潜能。
Description
技术领域
本发明涉及植物提取物和日化领域,具体为芒果活性部位在具有抗氧化化妆品领域中的应用。
背景技术
近年来,随着人们生活水平和审美标准的提高,越来越多的人追求、渴望白皙及洁润的肌肤。因此,具有防止由太阳光线及其它原因引起的色斑、色素沉着作用的美白类化妆品以及皮肤美白制剂的研究与开发,正日益受到各国化妆品生产商和研究者的重视,美白和抗氧化化妆品已成为护肤类化妆品的主流品种之
然而,随着化学合成化妆品中毒事件的频频发生,人们开始热衷于植物化妆品及回归自然的美容方法。
造成皮肤黑色素生成的原因有:遗传因素;紫外线、废气、活性氧等环境因素;体内氧化与抗氧化平衡失调;内分泌失调;微生态失衡;代谢紊乱;机体微量元素含量异常等。祖国医学则认为色素沉着的主要病因是:①肝气郁结;②肾阴不足;③气血淤阻;④劳伤脾土。在治疗上,全身疗法以疏肝、补肾、活血、益气健脾为主,外用以中药面膜和霜、膏剂居多。但此类资料多以临床报道为主,缺乏严密的科研设计、实验室研究和统计学处理。至今为止,也尚末发现开发出治疗“黄褐斑”中药搽剂的文献报道。因此,寻找高效且对人体无副作用或副作用小的美白祛斑制剂已成为目前药学及化妆品领域的一个研究热点。
美白机理美白剂的作用是通过抑制酪氨酸酶活性或者阻断酪氨酸生成黑色素的氧化途径,从而减少黑色素生成达到美白皮肤的效果。皮肤美白剂就是作用于皮肤黑色素生成、代谢过程中,抑制黑色素生成且符合规范的物质,但传统的皮肤美白剂,往往采用化学性物质,如具有增白作用的汞盐和祛斑作用的氢醌。这些化合物虽然有快速达到美白之功效,但对皮肤有毒副作用,长期使用会引起接触性皮炎或引起永久脱色等不良作用,在许多国家已被禁用。目前要求的皮肤美白剂应该符合两个标准:一是对酪氨酸酶活性有较高的抑制率,能显著的减少黑色素的生成;二是有较高的安全性,以人体皮肤无毒无刺激。熊果苷、VC及其衍生物和曲酸是目前国内外美白化妆品中较常使用的美白成分。为了开发符合“回归大自然”要求的化妆品,特别是安全,无副作用的美白产品,一些具有很好美白效果的中草药目前越来越受到消费者的青睐。在国际上化妆品发展最有代表性的国家美国、日本、法国和德国等国家中,中草药因其天然药效温和且不良作用少而被广泛认同,从中了解到近年来崇尚自然,远离化学污染的理念。特别是日本化妆品工业的发展趋势看,各化妆品公司使用的中草药已达200余种,目前,在日本含天然中草药的化妆品已占整个化妆品市场的50%以上。因此,寻找开发高效且对人体无副作用或副作用小的天然中草药皮肤美白祛斑制剂已成为目前化妆品领域的一个较被重视的课题。
芒果为漆树科植物芒果(MangiferaindicaLinn)的果实,为著名热带水果之一,素有“热带果王”之誉称。芒果品质极佳,营养价值很高,每100g鲜果含维生素C56mg,含糖11%,还含有丰富的维生素A、维生素B、维生素B2、蛋白质、胡萝卜素、淀粉、叶酸等。芒果含有多酚、黄酮和萜类化合物,具有抗脂质过氧化、抗病毒、抗肿瘤、抗菌、调节免疫、抗炎、祛痰、保肝利胆等作用,可用于治疗热滞腹痛、气胀、小儿疳积、消渴等症。
近年来对芒果的化学成分和生物活性研究发现芒果核含抗坏血酸、鞣花酸、没食子酸、没食子酸甲酯、儿茶素等化合物,具有行气散结,化痰消滞功效,可用于外感食滞引起的咳嗽痰多、胃脘饱胀和疝气痛,在体外对志贺痢疾杆菌、福氏痢疾杆菌、大肠埃希菌、铜绿假单胞菌、肺炎克雷伯菌、伤寒沙门菌等肠道与呼吸道致病细菌有抑制作用,此外,还对香蕉黑星病菌、番木瓜疫霉病菌和番木瓜炭疽病菌等水果真菌显示抑制活性;芒果皮含有挥发油、黄烷醇类、花色苷类、黄酮类、类黄酮类、黄酮醇类和酚酸类、类胡萝卜素、没食子酸和芒果苷等成分,具有抗氧化、增强免疫调节、止咳、化痰和促进气管分泌的作用,其中的多酚对由H2O2引起的小鼠红血球的氧化危害具有保护作用,对其引起的红血球氧化溶血和膜蛋白质降级具有抑制作用,可保护由过氧化氢引起的红血球膜的改变。
综合现有文献资料,未发现芒果及其所含成分具有美白作用和抗氧化作用的文献和专利报道。
发明内容
本发明旨在提供一种芒果活性部位的用途,将该芒果活性部位应用于制备具有抗氧化效果的化妆品。
本发明所要解决的技术问题是在于寻找开发高效且对人体无副作用或副作用小的天然植物抗氧化剂。本发明提供了一种在抗氧化领域有应用潜能的芒果活性部位。
一种芒果活性部位在制备具有抗氧化作用的化妆品领域中的应用。
所述的芒果活性部位的提取方法,步骤包括:
(1)取干燥的芒果粉末,加入乙醇溶液冷浸后提取2~5次,取滤液;
提取方法为常温(10~30℃)下用体积浓度为30%~95%乙醇溶液(优选为60%~75%)冷浸、超声提取10~60分钟;每次提取时,乙醇溶液与芒果粉末的用量比为5~15ml/g;
(2)合并滤液,去除乙醇后用大孔吸附树脂吸附,再用体积浓度为30%~90%的乙醇溶液(优选为30%~70%,最优选50%)洗脱,收集流分干燥;所述的大孔吸附树脂优选为AB-8树脂。
本发明的技术方案为,取芒果,干燥、粉碎成粗粉,取干燥粉末,以乙醇提取,滤液合并,减压回收溶剂,得到芒果粗提物;芒果粗提物经大孔吸附树脂吸附,以乙醇洗脱,收集流份,蒸干,得到芒果活性部位。测定所得到的活性部位清除自由基能力,其中30%~70%(体积浓度)乙醇溶液洗脱部位具有良好的抗氧化作用,尤其是50%(体积浓度)乙醇溶液洗脱部位,效果最佳。
通过上述方法得到的芒果活性部位,是一种天然的植物抗氧化剂,对人体无副作用,在抗氧化领域有应用潜能。这种芒果活性部位可用于制备具有抗氧化效果的化妆品:如化妆水、爽肤水、乳液、霜膏、洁面霜等。
具体实施方式
实施例1
芒果干燥粉末20g,室温下(10~30℃)以体积浓度为30%乙醇200ml冷浸、超声提取2次,每次10min(500W),取滤液合并,减压回收溶剂至干,取提取物适量,配制成0.5mg/ml溶液备用,测定其清除DPPH自由基能力,以便与后续制得的芒果活性部位的活性作比较。
结果:芒果粗提物清除DPPH自由基能力测试作用IC50为0.058mg/ml。
实施例2
芒果干燥粉末20g,室温下以体积浓度为60%乙醇200ml冷浸、超声提取2次,每次30min(500W),取滤液合并,减压回收溶剂至干,取提取物适量,配制成0.5mg/ml溶液备用,测定其清除DPPH自由基能力,以便与后续制得的芒果活性部位的活性作比较。
结果:芒果粗提物清除DPPH自由基能力测试作用IC50为0.187mg/ml。
实施例3
芒果干燥粉末20g,室温下以体积浓度为70%乙醇200ml冷浸、超声提取2次,每次30min(500W),取滤液合并,减压回收溶剂至干,取提取物适量,配制成0.5mg/ml溶液备用,测定其清除DPPH自由基能力,以便与后续制得的芒果活性部位的活性作比较。
结果:芒果粗提物清除DPPH自由基能力测试作用IC50为0.0198mg/ml。
实施例4
芒果干燥粉末20g,室温下以体积浓度为75%乙醇200ml冷浸、超声提取2次,每次30min(500W),取滤液合并,减压回收溶剂至干,取提取物适量,配制成0.5mg/ml溶液备用,测定其清除DPPH自由基能力,以便与后续制得的芒果活性部位的活性作比较。
结果:芒果粗提物清除DPPH自由基能力测试作用IC50为0.0897mg/ml。
实施例5
芒果干燥粉末20g,室温下(10~30℃)以体积浓度为95%乙醇200ml冷浸、超声提取2次,每次30min(500W),取滤液合并,减压回收溶剂至干,取提取物适量,配制成0.5mg/ml溶液备用,测定其清除DPPH自由基能力,以便与后续制得的芒果活性部位的活性作比较。
结果:芒果粗提物清除DPPH自由基能力测试作用IC50为0.0974mg/ml。
实施例6活性部位富集
取芒果干燥粉末50g,室温下(10~30℃)以体积浓度为70%乙醇500ml冷浸、超声提取2次,每次30min(500W),取滤液合并,减压回收溶剂至无醇味;经AB-8大孔吸附树脂吸附,依次以体积浓度为30%乙醇、50%乙醇、70%乙醇和90%乙醇洗脱,分别收集各流份、蒸干,分别得到30%乙醇洗脱部位、50%乙醇洗脱部位、70%乙醇洗脱部位和90%乙醇洗脱部位的芒果活性部位,并配制成不同浓度的溶液备用。
实施例7清除DPPH自由基能力测试
在化妆品领域,通常抗氧化性能的优劣是用清除DPPH自由基能力测试来表征的,清除DPPH自由基能力测试原理如下:
1,1-二苯基-2-三硝基苯肼[1,1-Diphenyl-2-picrylhydrazylradical2,2-Diphenyl-1-(2,4,6-trinitrophenyl)hydrazyl,DPPH]是一种稳定的氮中心有机自由基。DPPH法于1958年被提出,广泛用于地量测定生物试样、分类物质和食品的抗氧化能力。此法是根据DPPH自由基有单电子,在517nm处有一强吸收,其醇溶液呈紫色的特性。当有自由基清除剂存在时,由于与其单电子配对而使其吸收逐渐消失,其褪色程度与其接受的电子数量成定量关系,因而可用分光光度计进行快速的定量分析,来检测自由基清除情况,从而评价样品的抗氧化能力。其能力用清除率来表示,清除率越大,则表明其抗氧化能力越强。
试验方法:
1)将不同稀释度的待测样品溶液2ml加入试管中;
2)加入2ml76μmol/LDPPH乙醇溶液,混匀;
3)室温下避光在黑暗处反应30min;
4)在525nm处测定吸光度Abs;每个浓度重复三次测试以保证实验结果的准确性,最后取平均值作为拟合数据。
清除率I(%)=[1-(T-T0)/(C-C0)]×100%
式中:
T0:2ml水或DMSO加2mlDPPH溶液的吸光度;
T:2ml样品液加2mlDPPH溶液的吸光度;
C:2ml样品液加2ml95%乙醇的吸光度;
C0:2ml水或DMSO加2ml95%乙醇的吸光度;
按照上面公式计算清除率,清除率越大抗氧化能力越强。
半数抑制率(IC50)的计算:IC50值定义为清除率为50%时所需抗氧化剂的浓度。以样品的浓度对自由基清除率作图并进行拟合,读取计算IC50值,结果如表1。
表1芒果各部位清除DPPH自由基活性测试结果
实施例6所得30%乙醇、50%乙醇、70%乙醇和90%乙醇洗脱得到的芒果活性部位清除DPPH自由基的IC50分别为17.5μg/mL、1.9μg/mL、72.8μg/mL和107.2μg/mL。,由此可见,50%乙醇洗脱得到的部位清除DPPH自由基能力最强。
实施例6中,分别用30%、60%、75%和95%乙醇溶液冷浸和超声提取芒果干燥粉末,其余步骤操作相同。检测不同浓度乙醇洗脱部位的活性,结果与实施例7相似,50%乙醇洗脱部位的清除DPPH自由基能力最强,IC50为粗提物的约十分之一。
Claims (4)
1.芒果活性部位在制备具有抗氧化作用化妆品中的应用,其特征在于,所述的芒果活性部位的制备方法包括以下步骤:
(1)取干燥的芒果粉末,加入乙醇溶液冷浸后提取2~5次,取滤液;每次提取时,乙醇溶液与芒果粉末的用量比为5~15ml/g;
(2)合并滤液,去除乙醇后用大孔吸附树脂吸附,再用体积浓度为50%的乙醇溶液洗脱,收集流分干燥。
2.根据权利要求1所述芒果活性部位的应用,其特征在于,步骤(1)中,所述乙醇溶液的体积浓度为30%~95%、超声提取10~60分钟。
3.根据权利要求1或2所述芒果活性部位的应用,其特征在于,步骤(1)中,所述乙醇溶液的体积浓度为60%~75%。
4.根据权利要求1所述芒果活性部位的应用,其特征在于,所述大孔吸附树脂为AB-8大孔吸附树脂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210422046.3A CN103784356B (zh) | 2012-10-29 | 2012-10-29 | 芒果活性部位在制备抗氧化化妆品中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210422046.3A CN103784356B (zh) | 2012-10-29 | 2012-10-29 | 芒果活性部位在制备抗氧化化妆品中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103784356A CN103784356A (zh) | 2014-05-14 |
CN103784356B true CN103784356B (zh) | 2016-07-06 |
Family
ID=50660700
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210422046.3A Active CN103784356B (zh) | 2012-10-29 | 2012-10-29 | 芒果活性部位在制备抗氧化化妆品中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103784356B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105362128A (zh) * | 2015-11-11 | 2016-03-02 | 黄林海 | 一种具有美白保湿功效的护肤品 |
CN106176347B (zh) * | 2016-07-13 | 2019-01-15 | 广州科玛生物科技股份有限公司 | 一种男士润泽修护精华乳 |
CN106342840A (zh) * | 2016-08-26 | 2017-01-25 | 中国农业科学院茶叶研究所 | 一种防治茶树炭疽病的环保型制剂及其应用 |
US10898420B2 (en) * | 2016-10-31 | 2021-01-26 | L'oreal | Compositions containing phenolic compounds having synergistic antioxidant benefits |
US10624830B2 (en) | 2017-11-30 | 2020-04-21 | L'oreal | Aqueous compositions with mangiferin for cosmetic applications |
CN114983883A (zh) * | 2022-05-06 | 2022-09-02 | 南京斯拜科生物科技股份有限公司 | 一种用于化妆品中的水溶性芒果仁提取物的制备工艺 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101647794A (zh) * | 2009-09-11 | 2010-02-17 | 天津中医药大学 | 芒果叶中裂环芒果苷及含有裂环芒果苷的芒果叶提取物的新用途 |
CN101693730A (zh) * | 2009-10-16 | 2010-04-14 | 天津中医药大学 | 芒果叶苷及其制备方法与应用 |
-
2012
- 2012-10-29 CN CN201210422046.3A patent/CN103784356B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101647794A (zh) * | 2009-09-11 | 2010-02-17 | 天津中医药大学 | 芒果叶中裂环芒果苷及含有裂环芒果苷的芒果叶提取物的新用途 |
CN101693730A (zh) * | 2009-10-16 | 2010-04-14 | 天津中医药大学 | 芒果叶苷及其制备方法与应用 |
Non-Patent Citations (2)
Title |
---|
不同品种芒果总黄酮的抗氧化活性;文良娟等;《食品科学》;20111231;第32卷(第19期);第79-82页 * |
让你美丽的芒果化妆品;匿名;《中国科学美容》;20011231(第7期);第34页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103784356A (zh) | 2014-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103784356B (zh) | 芒果活性部位在制备抗氧化化妆品中的应用 | |
Gandía-Herrero et al. | Biological activities of plant pigments betalains | |
Milena et al. | Advantages of contemporary extraction techniques for the extraction of bioactive constituents from black elderberry (Sambucus nigra L.) flowers | |
Durgo et al. | The bioactive potential of red raspberry (Rubus idaeus L.) leaves in exhibiting cytotoxic and cytoprotective activity on human laryngeal carcinoma and colon adenocarcinoma | |
Barreca et al. | Evaluation of the antioxidant and cytoprotective properties of the exotic fruit Annona cherimola Mill.(Annonaceae) | |
Nag et al. | Antioxidant activities and cytotoxicity of Zingiber zerumbet (L.) Smith rhizome | |
Chiu et al. | The antioxidant and cytoprotective activity of Ocimum gratissimum extracts against hydrogen peroxide-induced toxicity in human HepG2 cells | |
CN101190281B (zh) | 梅树提取物及其制备方法和用途 | |
CN102961281B (zh) | 一种雪菊活性部位及其在制备美白化妆品中的应用 | |
Vulić et al. | Bioactive compounds and antioxidant properties of goji fruits (Lycium barbarum L.) cultivated in Serbia | |
Sohail et al. | Investigating the antioxidant potential of licorice extracts obtained through different extraction modes | |
CN102961280B (zh) | 雪菊活性部位在制备抗衰老化妆品中的应用 | |
Paradee et al. | A chemically characterized ethanolic extract of Thai Perilla frutescens (L.) Britton fruits (nutlets) reduces oxidative stress and lipid peroxidation in human hepatoma (HuH7) cells | |
Jaradat et al. | Phytoconstituents, antioxidant, sun protection and skin anti-wrinkle effects using four solvents fractions of the root bark of the traditional plant Alkanna tinctoria (L.) | |
KR20170132388A (ko) | 애기수영 또는 산수국의 추출물을 유효성분으로 함유하는 주름개선 또는 피부미백용 조성물 | |
Popova et al. | Melissa officinalis L.—GC profile and antioxidant activity | |
CN104523479B (zh) | 青刺尖提取物在美白用品中的应用及美白用品 | |
Atta et al. | Polyphenolic characterization and evaluation of multimode antioxidant, cytotoxic, biocompatibility and antimicrobial potential of selected ethno-medicinal plant extracts | |
Tamuly et al. | Assessment of antioxidant activity of six Ficus species—Underutilized fruits from Arunachal Pradesh in north east india | |
CN103393578B (zh) | 一种杨桃提取物及其应用 | |
CN103393574B (zh) | 一种水果提取物的混合物及其应用 | |
Atayoglu et al. | Evaluating bioactivity and bioaccessibility properties of the propolis extract prepared with l-lactic acid: An alternative solvent to ethanol for propolis extraction | |
Lee et al. | Antioxidant capacity and Hepatoprotective effect on ethanol-injured liver cell of lemon juice concentrates and its comparison with commercial Japanese apricot juice concentrates | |
John et al. | Evaluation of antioxidant and anticancer potential of Cassia tora leaves | |
CN110664679B (zh) | 一种具有美白抗衰老功效的中药组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 201403 Shanghai City, Fengxian District Lifenglu No. 12 Patentee after: Shanghai Natural Hall Group Co.,Ltd. Country or region after: China Address before: 201403 Shanghai City, Fengxian District Lifenglu No. 12 Patentee before: JALA Group Co. Country or region before: China |